Patient‐reported outcomes in HCC: A scoping review by the Pr... : Hepatology Patient‐reported
outcomes in HCC: A scoping review by the Practice Metrics Committee of the American …

Introduction Hepatocellular carcinoma (HCC) carries significant burden of disease, with high
mortality rates and poor prognosis. It is therefore important to consider quality of life (QoL) for …

Objectives This study sought to explore the use of novel natural language processing (NLP)
methods for classifying unstructured, qualitative textual data from interviews of patients with …

Background Compared with face-to-face mindfulness-based interventions (MBIs), online
mindfulness interventions may be more convenient for patients with limited resources and …

Background: Patient-reported outcomes (PRO) measures relevant to domains most
important to patients with HCC who received locoregional therapies are needed to advance …

PURPOSE In the phase III HIMALAYA study (ClinicalTrials. gov identifier: NCT03298451) in
unresectable hepatocellular carcinoma (uHCC), the Single Tremelimumab Regular Interval …

Introduction Biological and precision therapies are increasingly used in cancer treatment.
Although they may improve survival, they are also associated with various—and unique …

Objective This study aimed to synthesize the available knowledge of identifying
hepatocellular carcinoma (HCC) symptoms and symptom clusters in patients with HCC and …

Introduction Biological and precision therapies are increasingly used in cancer treatment.
Although they may improve survival, they are also associated with various—and unique …

Background Radiation therapy has attracted much attention in the treatment of patients with
hepatocellular carcinoma (HCC). However, the association between radiotherapy-related …